Nomifensine attenuates d-amphetamine-induced dopamine terminal neurotoxicity in the striatum of rats

Chinese Journal of Physiology

Volumn 43, Issue 2, 2000, Pages 69-74

  Wan, Fang Jung ^a,b   Shiah, I Shin ^b   Lin, Hui Ching ^a   Huang, San Yuan ^b   Tung, Che Se ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

D amphetamine; Dopamine tansporter; Monoamine oxidase; Oxidative stress; Striatum

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); DEXAMPHETAMINE; DOPAMINE; DOPAMINE TRANSPORTER; NOMIFENSINE; SELEGILINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; MALE; NERVE ENDING; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT;

EID: 0033938479     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ali, S.F., Newport, G.D., Holson, R.R., Slikker W. Jr. and Bowyer J.F. Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res. 658: 33-38, 1994.
2. Bowyer, J.F., Davies, D.L., Schmued, L., Broening, H.W., Newport, G.D., Slikker, Jr. W. and Holson, R.R. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J. Pharmacol. Exp. Ther. 268: 1571-1580, 1994.
3. Buisson, A., Callebert, J., Mathieu, E., Plotkine, M. and Boulu, R. G. Striatal protection induced by lesioning the substantia nigra of rats subjected to focal ischemia. J. Neurochem. 59(3): 1153-1157, 1992.
4. Cadet, J.L. and Brannock, C. Free radicals and the pathophysiology of brain dopamine systems. Neurochem. Int. 32: 117-131, 1998.
5. Cadet, J.L., Sheng. P., Ali, S., Rothman, R., Carlson, E. and Epstein, C. Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 62: 380-383, 1994.
6. Carrillo, M.C., Kitani, K., Kanai, S., Sato, Y., Miyasaka, K. and Ivy, G.O. The effect of a long-term treatment with (-)deprenyl on antioxidant enzyme activities in selective brain regions in old female Fischer-344 rat. Biochem. Pharmacol. 47: 1333-1338, 1994.
7. Coyle, J.T. and Puttfarcken, P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262: 689-695, 1993.
8. Cubells, J.F., Rayport, S., Rajendran, G. and Sulzer, D. Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J. Neurosci. 14: 2260-2771, 1994.
9. De Vito, M.J. and Wagner, G.C. Methamphetamine-induced neuronal damage: a possible role for free radicals. Neurophamacology 28: 1145-1150, 1989.
10. Delle Donne, K.T. and Sonsalla, P.K. Protection against methamphetamine-induced neurotoxicity to neostriatal dopaminergic neurons by adenosine receptor activation. J. Pharmacol. Exp. Ther. 271: 1320-1326, 1994.
11. Filloux, F. and Wamsley, J.K. Dopaminergic modulation of excitotoxicity in rat striatum: evidence from nigrostriatal lesions. Synapse 8: 281-288, 1991.
12. Fuller, R.W. and Hemrick-Luecke, S. Long-lasting depletion of striatal dopamine by a single injection of amphetamine in iprindole-treated rats. Science 209: 395-397, 1980.
13. Fumagalli, F., Gainetdinov, R.R., Valenzano, K.J. and Caron, M.G. Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter. J. Neurosci. 18: 4861-4869, 1998.
14. Graham, D.G., Tiffany, S.M., Bell, W.R. and Gutknecht, W.F. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward Cl300 neuroblastoma cells in vitro. Mol. Pharmacol. 14: 644-653, 1978.
15. Halliwell, B., Kaur, H. and Ingelman-sundberg, M. Hydroxylation of salicylate as an assay for hydroxyl radicals: a cautionary note. Free Radic. Biol. Med. 10: 439-441, 1991.
16. Hastings, T.G., Lewis, D.A. and Zigmond, M.J. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc. Natl. Acad. Sci. USA 93: 1956-1961, 1996.
17. Henneberry, R.C., Novelli, A., Cox, J.A. and Lysko, P.G. Neurotoxicity at the N-methyl-D-aspartate receptor in energy-compromised neurons. Ann. N.Y. Acad. Sci. 568: 225-233, 1989.
18. Huang, N.K., Wan, F.J., Tseng, C.J. and Tung, C.S. Amphetamine induces hydroxyl radical formation in the striatum of rats. Life Sci. 61: 2219-2229, 1997.
19. Kil, H.Y., Zhang, J. and Piantadosi, C.A. Brain temperature alters hydroxyl radical production during cerebral ischemia/reperfusion in rats. J. Cereb. Blood Flow Metab. 16: 100-106, 1996.
20. Kogan, F.J., Nichols, W.K. and Gibb, J.W. Influence of methamphetamine on nigral and striatal tyrosine hydoxylase activity and on striatal dopamine levels. Eur. J. Pharmacol. 36: 363-371, 1976.
21. Kondo, T., Ito, T. and Sugita, T. Bromocriptine scavenges methamphetamine-induced hydroxyl radicals and attenuates dopamine depletion in mouse striatum. Ann. N.Y. Acad. Sci. 738: 222-229, 1994.
22. La Voie, M.J. and Hastings, T.G. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J. Neurosci. 19: 1484-1491, 1999.
23. Lin, H.C., Kang, B.H., Wong, C.S., Mao, S.P. and Wan, F.J. Systemic administration of d-amphetamine induces a delayed production of nitric oxide in the striatum of rats. Neurosci. Lett. 276: 141-144, 1999.
24. Melamed, E., Rosenthal, J., Globus, M., Cohen, O. and Uzzan, A. Suppression of MPTP-induced dopaminergic neurotoxicity in mice by nomifensine and L-DOPA. Brain Res. 342: 401-404, 1985.
25. O'Dell, S.J., Weihmuller, F.B. and Marshall, J.F. Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity. Brain Res. 564: 256-260, 1991.
26. Ricaurte, G.A., Guillery, R.W. Seiden, L.S., Schuster, C.R. and Moore, R.Y. Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res. 235: 93-103, 1982.
27. Schmidt, C.J., Ritter, J.K. Sonsalla, P.K., Hanson, G.R. and Gibb, J.W. Role of dopamine in the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther. 233: 539-544, 1985.
28. Seiden, L.S. and Vosmer, G. Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine. Pharmacol. Biochem. Behav. 21: 29-31, 1984.
29. Slivka, A. and Cohen, G. Hydroxyl radical attack on dopamine. J. Biol. Chem. 260: 15466-15472, 1985.
30. Sonsalla, P.K., Nicklas, W.J. and Heikkila, R.E. Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 243: 398-400, 1989.
31. Vizuete, M.L., Steffen, V., Ayala, A., Cano, J. and Machado, A. Protective effect of deprenyl against 1-methyl-4-phenyl-pyridinium neurotoxicity in rat striatum. Neurosci. Lett. 152: 113-116, 1993.
32. Wagner, G.C., Lucot, J.B., Schuster, C.R. and Seiden, L.S. α-Methyltyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes. Brain Res. 270: 285-288, 1983.
33. Wan, F.J., Lin, H.C., Huang, K.L., Tseng, C.J. and Wong, C.S. Systemic administration of d-amphetamine induces long-lasting oxidative stress in the rat striatum. Life Sci. 66: 205-212, 2000.
34. Wan, F.J., Lin, H.C., Kang, B.H., Tseng, C.J. and Tung, C.S. d-Amphetamine-induced energy and dopamine depletion in the striatum is attenuated by nicotinamide pretreatment. Brain Res. Bull. 50: 167-171, 1999.
35. Wan, F.J., Lin, H.C., Lin, Y.S. and Tseng, C.J. Intra-striatal infusion of d-amphetamine induces hydroxyl radical formation: inhibition by MK-801 pretreatment. Neuropharmacology 39: 419-426, 2000.